{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:16:33Z","timestamp":1778224593091,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41388-019-0757-y","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T15:04:41Z","timestamp":1551366281000},"page":"4773-4787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation"],"prefix":"10.1038","volume":"38","author":[{"given":"Anne","family":"Kresinsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina M.","family":"Schn\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse D.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz C.","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Ast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Magnus","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Thilo","family":"Figge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Hilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian H.","family":"Heidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank- D.","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg P.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"757_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND. et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"757_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2007.11.005","volume":"12","author":"S Fr\u00f6hling","year":"2007","unstructured":"Fr\u00f6hling S, Scholl C, Levine RL, Loriaux M, Boggon TJ, Bernard OA. et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell. 2007;12:501\u201313.","journal-title":"Cancer Cell"},{"key":"757_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.leukres.2006.09.018","volume":"31","author":"RF Pinheiro","year":"2007","unstructured":"Pinheiro RF, Moreira Ede S, Silva MR, Greggio B, Alberto FL, Chauffaille Mde L. FLT3 mutation and AML\/ETO in a case of Myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis. Leukemia Res. 2007;31:1015\u20138.","journal-title":"Leukemia Res"},{"key":"757_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc1169","volume":"3","author":"DL Stirewalt","year":"2003","unstructured":"Stirewalt DL, Radich JP. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer. 2003;3:650\u201365.","journal-title":"Nat Rev Cancer"},{"key":"757_CR5","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","volume":"96","author":"M Mizuki","year":"2000","unstructured":"Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, M\u00fcller C. et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood. 2000;96:3907\u201314.","journal-title":"Blood"},{"key":"757_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.onc.1203354","volume":"19","author":"F Hayakawa","year":"2000","unstructured":"Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H. et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene. 2000;19:624\u201331.","journal-title":"Oncogene"},{"key":"757_CR7","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1182\/blood-2011-02-336446","volume":"119","author":"R Godfrey","year":"2012","unstructured":"Godfrey R, Arora D, Bauer R, Stopp S, Muller JP, Heinrich T. et al. Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1\/ PTPRJ. Blood. 2012;119:4499\u2013511.","journal-title":"Blood"},{"key":"757_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/leu.2015.234","volume":"30","author":"AK Jayavelu","year":"2016","unstructured":"Jayavelu AK, M\u00fcller JP, Bauer R, Bohmer SA, Lassig J, Cerny-Reiterer S. et al. NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia. 2016;30:473\u201383.","journal-title":"Leukemia"},{"key":"757_CR9","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","volume":"111","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, Fan J, Datta K, Kim KT, Grosu D, Shapiro P. et al. Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood. 2008;111:3173\u201382.","journal-title":"Blood"},{"key":"757_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","volume":"12","author":"BH Lee","year":"2007","unstructured":"Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE. et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell. 2007;12:367\u201380.","journal-title":"Cancer Cell"},{"key":"757_CR11","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1182\/blood-2007-08-109942","volume":"111","author":"L Li","year":"2008","unstructured":"Li L, Piloto O, Nguyen HB, Greenberg K, Takamiya K, Racke F. et al. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood. 2008;111:3849\u201358.","journal-title":"Blood"},{"key":"757_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1182\/blood.V99.1.310","volume":"99","author":"LM Kelly","year":"2002","unstructured":"Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL, Gilliland DG. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood. 2002;99:310\u20138.","journal-title":"Blood"},{"key":"757_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A. et al. Protein tyrosine phosphatases in the human genome. Cell. 2004;117:699\u2013711.","journal-title":"Cell"},{"key":"757_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrc1837","volume":"6","author":"A \u00d6stman","year":"2006","unstructured":"\u00d6stman A, Hellberg C, B\u00f6hmer FD. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer. 2006;6:307\u201320.","journal-title":"Nat Rev Cancer"},{"key":"757_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1742-4658.2012.08655.x","volume":"280","author":"F B\u00f6hmer","year":"2013","unstructured":"B\u00f6hmer F, Szedlacsek S, Tabernero L, Ostman A, den Hertog J. Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis. FEBS J. 2013;280:413\u201331.","journal-title":"FEBS J"},{"key":"757_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/smim.2000.0218","volume":"12","author":"DR Alexander","year":"2000","unstructured":"Alexander DR. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol. 2000;12:349\u201359.","journal-title":"Semin Immunol"},{"key":"757_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.bbadis.2013.05.022","volume":"1832","author":"WJ Hendriks","year":"2013","unstructured":"Hendriks WJ, Pulido R. Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities. Biochim Biophys Acta. 2013;1832:1673\u201396.","journal-title":"Biochim Biophys Acta"},{"key":"757_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/smim.1998.0122","volume":"10","author":"AL DeFranco","year":"1998","unstructured":"DeFranco AL, Chan VW, Lowell CA. Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin Immunol. 1998;10:299\u2013307.","journal-title":"Semin Immunol"},{"key":"757_CR19","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1084\/jem.20080072","volume":"205","author":"S Shivtiel","year":"2008","unstructured":"Shivtiel S, Kollet O, Lapid K, Schajnovitz A, Goichberg P, Kalinkovich A. et al. CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules. J Exp Med. 2008;205:2381\u201395.","journal-title":"J Exp Med"},{"key":"757_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/sj.leu.2400847","volume":"11","author":"F Lacombe","year":"1997","unstructured":"Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E. et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11:1878\u201386.","journal-title":"Leukemia"},{"key":"757_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-10-19","volume":"10","author":"D Arora","year":"2012","unstructured":"Arora D, Kothe S, van den Eijnden M, Hooft van Huijsduijnen R, Heidel F, Fischer T. et al. Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal. 2012;10:19","journal-title":"Cell Commun Signal"},{"key":"757_CR22","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1074\/jbc.M110.205021","volume":"286","author":"D Arora","year":"2011","unstructured":"Arora D, Stopp S, Bohmer SA, Schons J, Godfrey R, Masson K. et al. Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling. J Biol Chem. 2011;286:10918\u201329.","journal-title":"J Biol Chem"},{"key":"757_CR23","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1182\/blood-2011-01-328096","volume":"118","author":"L Li","year":"2011","unstructured":"Li L, Bailey E, Greenblatt S, Huso D, Small D. Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3\/ITD knockin mice. Blood. 2011;118:4935\u201345.","journal-title":"Blood"},{"key":"757_CR24","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1182\/blood-2016-07-730614","volume":"129","author":"AR Pyzer","year":"2017","unstructured":"Pyzer AR, Stroopinsky D, Rajabi H, Washington A, Tagde A, Coll M. et al. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Blood. 2017;129:1791\u2013801.","journal-title":"Blood"},{"key":"757_CR25","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1128\/MCB.25.9.3690-3703.2005","volume":"25","author":"DE Schmidt-Arras","year":"2005","unstructured":"Schmidt-Arras DE, B\u00f6hmer A, Markova B, Choudhary C, Serve H, B\u00f6hmer FD. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol Cell Biol. 2005;25:3690\u2013703.","journal-title":"Mol Cell Biol"},{"key":"757_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","volume":"36","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, B\u00f6hmer FD. et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell. 2009;36:326\u201339.","journal-title":"Mol Cell"},{"key":"757_CR27","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood.V86.5.1661.bloodjournal8651661","volume":"86","author":"M Gabbianelli","year":"1995","unstructured":"Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P. et al. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors\/monocytic precursors. Blood. 1995;86:1661\u201370.","journal-title":"Blood"},{"key":"757_CR28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.V87.4.1317.bloodjournal8741317","volume":"87","author":"LS Rusten","year":"1996","unstructured":"Rusten LS, Lyman SD, Veiby OP, Jacobsen SE. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34\u2009+\u2009bone marrow progenitor cells in vitro. Blood. 1996;87:1317\u201325.","journal-title":"Blood"},{"key":"757_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456\u201369.","journal-title":"Cell"},{"key":"757_CR30","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","volume":"100","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100:1532\u201342.","journal-title":"Blood"},{"key":"757_CR31","first-page":"2058","volume":"9","author":"JE Rasko","year":"1995","unstructured":"Rasko JE, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3\/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia. 1995;9:2058\u201366.","journal-title":"Leukemia"},{"key":"757_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1189\/jlb.3CE0915-445RR","volume":"99","author":"I Voronov","year":"2016","unstructured":"Voronov I, Manolson MF. Editorial: Flt3 ligand-friend or foe? J Leukocyte Biol. 2016;99:401\u20133.","journal-title":"J Leukocyte Biol"},{"key":"757_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s001980070124","volume":"11","author":"C Schulte","year":"2000","unstructured":"Schulte C, Beelen DW, Schaefer UW, Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int. 2000;11:344\u201353.","journal-title":"Osteoporos Int"},{"key":"757_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","volume":"14","author":"PR Ebeling","year":"1999","unstructured":"Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res. 1999;14:342\u201350.","journal-title":"J Bone Miner Res"},{"key":"757_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2007.11.024","volume":"28","author":"JW Zhu","year":"2008","unstructured":"Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 2008;28:183\u201396.","journal-title":"Immunity"},{"key":"757_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RG Verhaak","year":"2009","unstructured":"Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S. et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94:131\u20134.","journal-title":"Haematologica"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0757-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-0757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:44Z","timestamp":1684617344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-0757-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":36,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-0757-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}